×

Regulus Hep C drug shows promise

5:30 PM ET Wed, 22 Oct 2014

Kleanthis Xanthopoulos, Regulus Therapeutics CEO and president, discusses the substantial reaction shown by a single dose of the company's Hepatitis-C drug.